Skip to main content
MJFF Feed

Parkinson's Disease Patient and Scientific Communities Converge for Landmark Meeting

Parkinson's Disease Patient and Scientific Communities Converge for Landmark Meeting

Last month, hundreds of Parkinson’s disease (PD) advocates descended on Grand Rapids, Michigan for a one-of-a-kind patient-centered meeting focused on how people with PD can be meaningful partners in the clinical trial process.  All part of the larger Grand Challenges in Parkinson’s Disease Symposium, the Rallying to the Challenge breakout group brought patients face-to-face with nearly 250 PD researchers and some of the world’s leading PD organizations to talk about the biggest barriers to volunteer involvement in clinical research, and how to knock them down.  

At present, 85 percent of trials face delays and 30 percent never even get off the ground because of a lack of volunteers.  What’s more, of the 60 percent of Parkinson’s patients who say they are willing to participate in a clinical trial, only about 10 percent actually do. 

Determined to improve these odds, the Rallying to the Challenge group focused their attention on addressing the many misconceptions of clinical trial participation, improving communication between volunteers and study teams, and increasing the public’s awareness of the trial opportunities available to them.

We must make patient involvement the rule, not the exception,” urged Tom Isaacs, co-founder of the Cure Parkinson’s Trust, a UK-based Parkinson’s research organization responsible for organizing the symposium.

To learn more about how you can get involved in PD clinical research, create a profile on Fox Trial Finder. Click here for a complete recap of the meeting.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.